(IN BRIEF) Siemens Digital Industries Software and NEC Corporation have signed a Technology Partner Program Agreement to jointly develop an automated robot teaching solution that integrates NEC’s Robot Task Planning service with Siemens’ Process Simulate software. The collaboration, part of … Read the full press release
Posted in Artificial Intelligence (AI), Energy, Gas & Oil, Environment, France, Germany, Industrial, Infrastructure & Utilities, News, Technology
Tagged 3D robot simulation, AI simulation, automated teaching, BluStellar, digital transformation, Digital Twin, Dx, Faster Production, industrial automation, Industry 4.0, Kosuke Hidashima, Kunihiko Horita, manufacturing innovation, NEC, NEC Robot Task Planning, Process Simulate, production optimization, robotics, Siemens, Siemens and NEC Drive Digital Transformation in Manufacturing with Automated Robot Teaching, Siemens Digital Industries Software, Siemens-NEC Partnership Delivers AI-Driven Robot Simulation for Smarter, smart factories, Tecnomatix
(IN BRIEF) GSK announced that its B7-H3-targeted antibody-drug conjugate GSK5764227 (GSK’227) has been granted Orphan Drug Designation (ODD) by the European Medicines Agency (EMA) for the treatment of pulmonary neuroendocrine carcinoma, including small-cell lung cancer (SCLC). The designation is supported … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ADC, antibody-drug conjugate, ARTEMIS-001, B7-H3, breakthrough therapy designation, cancer research, EMA, EMA Grants Orphan Drug Designation to GSK’s B7-H3 Antibody-Drug Conjugate for Pulmonary Neuroendocrine Carcinoma, FDA, GSK, GSK Strengthens Oncology Pipeline With EMA Orphan Drug Status for GSK’227 in Small-Cell Lung Cancer, GSK5764227, GSK’227, immuno-oncology, lung cancer, NEC, ODD, oncology, oncology pipeline, orphan drug designation, PRIME designation, pulmonary neuroendocrine carcinoma, relapsed or refractory, SCLC, Small cell lung cancer, solid tumours, targeted therapy
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?